In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency

Journal of Nutrition

Volumn 145, Issue 1, 2015, Pages 32-40

  Bogusiewicz, Anna ^a   Boysen, Gunnar ^b   Mock, Donald M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Biomarkers; Biotin; Carnitine; Intermediary metabolism; Mass spectrometry

Indexed keywords

ACETYLCARNITINE; ACYL COENZYME A; ACYLCARNITINE; BIOTIN; CARBOXYLASE; CARNITINE; METHYLMALONYLCARNITINE; PROPIONYLCARNITINE; UNCLASSIFIED DRUG; 3-HYDROXYISOVALERYLCARNITINE; BIOLOGICAL MARKER; CULTURE MEDIUM;

ARTICLE; BIOTIN DEFICIENCY; CARNITINE DEFICIENCY; CONTROLLED STUDY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; INBORN ERROR OF METABOLISM; LIQUID CHROMATOGRAPHY; PATHOGENESIS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TRANSESTERIFICATION; ANALOGS AND DERIVATIVES; CHEMISTRY; CULTURE MEDIUM; DEFICIENCY; FEMALE; LABORATORY DIAGNOSIS; METABOLISM; PHYSIOLOGY; PREGNANCY; URINE;

ACYL COENZYME A; BIOMARKERS; BIOTIN; CARNITINE; CHROMATOGRAPHY, LIQUID; CULTURE MEDIA; FALSE NEGATIVE REACTIONS; FEMALE; HEP G2 CELLS; HUMANS; PREGNANCY; TANDEM MASS SPECTROMETRY;

EID: 84919781296     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.201343     Document Type: Article

References (36)

1. Mock DM, Matthews NI. Biotin and pantothenic acid. In: Stipanuk MH, Caudill MA, editors. Biochemical, physiological and molecular aspects of human nutrition: 3rd ed. St. Louis (MO): Saunders/Elsevier; 2012.
2. Mock DM, Mock NI, Stewart CW, LaBorde JB, Hansen DK. Marginal biotin deficiency is teratogenic in ICR mice. J Nutr 2003;133:2519-25.
3. Mock DM. Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in the mouse. J Nutr 2009;139:154-7.
4. Said HM. Biotin bioavailability and estimated average requirement: why bother? Am J Clin Nutr 1999;69:352-3.
5. Perry CW,West AA, Gayle AA, Lucas LK, Yan J, Jiang X, Malysheva O, Caudill MA. Pregnancy and lactation alter biomarkers of biotin metabolism in women consuming a controlled diet. J Nutr 2014;144:1977-84.
6. Stratton SL, Horvath TD, Bogusiewicz A, Matthews NI, Henrich CL, Spencer HJ, Moran JH, Mock DM. Urinary excretion of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. J Nutr 2011;141:353-8.
7. Cho S, Cha Y. Pregnancy increases urinary loss of carnitine and reduces plasma carnitine in Korean women. Br J Nutr 2005;93(5):685-91.
8. Keller U, van der Wal C, Seliger G, Scheler C, Ropke F, Eder K. Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration. Eur J Clin Nutr 2009;63:1098-105.
9. Ringseis R, Hanisch N, Seliger G, Eder K. Low availability of carnitine precursors as a possible reason for the diminished plasma carnitine concentrations in pregnant women. BMC Pregnancy Childbirth 2010;10:10-7.
10. Bogusiewicz A, Horvath TD, Stratton SL, Mock DM, Boysen G. Measurement of acylcarnitine substrate to product ratios specific to biotin-dependent carboxylases offers a combination of indicators of biotin status in humans. J Nutr 2012;142:1621-5.
11. Arafa HM. Carnitine deficiency: a possible risk factor in paracetamol hepatotoxicity. Arch Toxicol 2009;83:139-50.
12. Al-Majed AA, Sayed-Ahmed MM, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Shabanah OA. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res 2006;53(3):278-86.
13. Spaniol M, Kaufmann P, Beier K, Wuthrich J, Torok M, Scharnagl H, Marz W, Krahenbuhl S. Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. J Lipid Res 2003;44:144-53.
14. Zaugg CE, Spaniol M, Kaufmann P, Bellahcene M, Barbosa V, Tolnay M, Buser PT, Krahenbuhl S. Myocardial function and energy metabolism in carnitine-deficient rats. Cell Mol Life Sci 2003;60:767-75.
15. Cederblad G, Fahraeus L, Lindgren K. Plasma carnitine and renal-carnitine clearance during pregnancy. Am J Clin Nutr 1986;44:379-83.
16. Solórzano-Vargas RS, Pacheco-Alvarez D, Leon-Del-Rio A. Holocarboxylase synthetase is an obligate participant in biotin-mediated regulation of its own expression and of biotin-dependent carboxylases mRNA levels in human cells. Proc Natl Acad Sci USA 2002;99:5325-30.
17. Mall GK, Chew YC, Zempleni J. Biotin requirements are lower in human Jurkat lymphoid cells but homeostatic mechanisms are similar to those of HepG2 liver cells. J Nutr 2010;140:1086-92.
18. Sealey WM, Stratton SL, Mock DM, Hansen DK. Marginal maternal biotin deficiency in CD-1 mice reduces fetal mass of biotin-dependent carboxylases. J Nutr 2005;135:973-7.
19. Mock DM. Determinations of biotin in biological fluids. In: McCormick DB, Suttie JW, Wagner C, editors. Methods in enzymology. New York: Academic Press; 1997. p. 265-75.
20. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009;106:3698-703.
21. Jones DR, Boysen G, Miller GP. Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:1056-62.
22. Zempleni J, Mock D. Marginal biotin deficiency is teratogenic. Proc Soc Exp Biol Med 2000;223:14-21.
23. Mock NI, Malik MI, Stumbo PJ, Bishop WP, Mock DM. Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased status in experimental biotin deficiency. Am J Clin Nutr 1997;65:951-8.
24. Mock DM, Henrich CL, Carnell N, Mock NI. Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge. Am J Clin Nutr 2002;76:1061-8.
25. Talián GC, Komlosi K, Decsi T, Koletzko B, Melegh B. Determination of carnitine ester patterns during the second half of pregnancy, at delivery, and in neonatal cord blood by tandem mass spectrometry: complex and dynamic involvement of carnitine in the intermediary metabolism. Pediatr Res 2007;62:88-92.
26. Rebouche CJ. Carnitine function and requirements during the life cycle. FASEB J 1992;6(15):3379-86.
27. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003;42:941-67.
28. Zammit VA, Ramsay RR, Bonomini M, Arduini A. Carnitine, mitochondrial function and therapy. Adv Drug Deliv Rev 2009;61:1353-62.
29. Rebouche CJ, Engel AG. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes: evidence for alterations in tissue carnitine transport. J Clin Invest 1984;73:857-67.
30. Horvath TD, Stratton SL, Bogusiewicz A, Pack L, Moran J, Mock DM. Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans. Anal Chem 2010;82:4140-4.
31. Mock DM, Stratton S, Horvath T, Bogusiewicz A, Matthews N, Henrich CL, Dawson AM, Spencer HJ, Owen SN, Boysen G, et al. Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans. J Nutr 2011;141:1925-30.
32. Shigematsu Y, Bykov IL, Liu YY, Nakai A, Kikawa Y, Sudo M, Fujioka M. Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and without L-carnitine supplementation. J Inherit Metab Dis 1994;17:678-90.
33. Heinonen OJ, Takala J. Moderate carnitine depletion and long-chain fatty acid oxidation, exercise capacity, and nitrogen balance in the rat. Pediatr Res 1994;36:288-92.
34. Spaniol M, Brooks H, Auer L, Zimmermann A, Solioz M, Stieger B, Krahenbuhl S. Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 2001;268(6):1876-87.
35. Chalmers RA, Roe CR, Stacey TE, Hoppel CL. Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of L-carnitine. Pediatr Res 1984;18:1325-8.
36. Matsuishi T, Stumpf DA, Seliem M, Eguren LA, Chrislip K. Propionate mitochondrial toxicity in liver and skeletal muscle: acyl CoA levels. Biochem Med Metab Biol 1991;45:244-53.